Physician profile
Kapil Puri
NPI 1962494211
$9,027.29
in general payments reported to CMS, 2019-2025
34 companies · $790 in 2025
The $790 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $363 · 2020: $718 · 2021: $1,101 · 2022: $1,226 · 2023: $1,233 · 2024: $3,596 · 2025: $790.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,798 · Food and Beverage: $1,821.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,798.06 |
| Food and Beverage | $1,821.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,928.09 | 2021-2025 | Urolift |
| Profound Medical Corp. | $1,679.21 | 2024-2025 | Tulsa-Pro |
| Axonics, INC. | $1,301.60 | 2021-2024 | Axonics, Bulkamid |
| Procept Biorobotics Corporation | $1,146.80 | 2024-2025 | Aquabeam System |
| Astellas Pharma US INC | $451.82 | 2019-2025 | Xtandi, Myrbetriq |
| Urovant Sciences INC | $287.39 | 2021-2022 | |
| Pfizer INC. | $252.00 | 2019-2020 | |
| Neotract INC. | $249.86 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $216.54 | 2019-2023 | Xiaflex, Aveed |
| Immunitybio, INC. | $210.40 | 2025 | |
| Calyxo, INC. | $137.67 | 2025 | Cvac Aspiration System |
| Boston Scientific Corporation | $117.00 | 2022-2025 | Axonics |
| Comsort, INC | $100.00 | 2019 | |
| Urogen Pharma, INC. | $93.84 | 2020-2025 | Jelmyto |
| Melinta Therapeutics, LLC | $84.10 | 2023 | Kimyrsa |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Photocure INC | $76.92 | 2022-2024 | Cysview |
| C. R. Bard, INC. & Subsidiaries | $70.23 | 2020 | |
| Sumitomo Pharma America, INC. | $68.52 | 2023-2024 | Gemtesa |
| Abbvie INC. | $65.09 | 2020-2025 | |
| Medtronic, INC. | $62.44 | 2022-2024 | Interstim, Nuro |
| Clarus Therapeutics INC. | $58.25 | 2021 | |
| Antares Pharma, INC. | $45.52 | 2020-2021 | |
| Tolmar, INC. | $44.62 | 2024 | |
| Blue Earth Diagnostics | $40.55 | 2020-2021 | |
| Progenics Pharmaceuticals, INC. | $38.98 | 2025 | |
| Janssen Biotech, INC. | $37.60 | 2022-2025 | Rybrevant, Carvykti |
| Olympus America INC. | $36.25 | 2024 | Itind System |
| Abc Home Medical Supply, INC. | $34.42 | 2022-2024 | |
| Hollister Incorporated | $19.38 | 2024 | Vapro Plus Pocket |
| Bayer Healthcare Pharmaceuticals INC. | $17.12 | 2021 | |
| Myovant Sciences INC. | $15.24 | 2021 | |
| Ethicon US, LLC | $15.02 | 2019 | |
| Coloplast Corp | $13.20 | 2023 | Altis |
| Tolmar Pharmaceuticals, INC. | $11.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kapil Puri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.